Beijing (2)

B Cell Lymphoma (2)

Solid Tumors (1)

Recruiting (1)

Unknown status (1)

phase 1 (1)

phase 1/phase 2 (1)

Han weidong (1)

Shanghai Hengrui Pharmaceutical Co., Ltd. (1)

cytokine-induced killer cell (1)

decitabine (1)

shr-a1912 (1)

drug (2)

biological (1)

Industry (1)

Other (1)

Interventional (2)

b cell lymphoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Apr 15, 2022

Unknown status

Beijing, Beijing, China

Biotherapeutic Department of Chinese PLA General Hospital

Jan 26, 2016